Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Appointed director Inv. presentation Cert. of designation Quarterly results Acq. announced
|
HARROW HEALTH, INC. (IMMY)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/15/2023 |
4
| BAUM MARK L (CEO) has filed a Form 4 on HARROW HEALTH, INC.
Txns:
| Bought 5,800 shares
@ $17.05, valued at
$98.9k
|
|
08/15/2023 |
4
| Makary Martin A. (Director) has filed a Form 4 on HARROW HEALTH, INC.
Txns:
| Bought 20,000 shares
@ $16.92, valued at
$338.4k
|
|
07/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/04/2023 |
4
| BAUM MARK L (CEO) has filed a Form 4 on HARROW HEALTH, INC.
Txns:
| Paid exercise price by delivering 117,633 shares
@ $20.97, valued at
$2.5M
Exercised 180,000 options to buy
@ $8.99, valued at
$1.6M
Granted 762,300 restricted stock units
@ $0 |
|
04/04/2023 |
4
| SAHAREK JOHN P. (Chief Commercial Officer) has filed a Form 4 on HARROW HEALTH, INC.
Txns:
| Granted 277,200 restricted stock units
@ $0 |
|
04/04/2023 |
4
| BOLL ANDREW R. (CFO) has filed a Form 4 on HARROW HEALTH, INC.
Txns:
| Paid exercise price by delivering 34,442 shares
@ $21.16, valued at
$728.8k
Exercised 90,000 options to buy
@ $6, valued at
$540k
Granted 346,500 restricted stock units
@ $0 |
|
01/03/2023 |
4
| BOLL ANDREW R. (CFO) has filed a Form 4 on HARROW HEALTH, INC.
Txns:
| Paid exercise price by delivering 9,602 shares
@ $14.76, valued at
$141.7k
Exercised 23,000 options to buy
@ $0 |
|
01/03/2023 |
4
| BAUM MARK L (CEO) has filed a Form 4 on HARROW HEALTH, INC.
Txns:
| Paid exercise price by delivering 35,179 shares
@ $14.76, valued at
$519.2k
Exercised 88,000 options to buy
@ $0 |
|
12/23/2022 |
4
| BAUM MARK L (CEO) has filed a Form 4 on HARROW HEALTH, INC.
Txns:
| Bought 25,000 shares
@ $13.39, valued at
$334.8k
|
|
12/23/2022 |
4
| BOLL ANDREW R. (CFO) has filed a Form 4 on HARROW HEALTH, INC.
Txns:
| Bought 2,500 shares
@ $13.54, valued at
$33.9k
|
|
12/23/2022 |
4
| Makary Martin A. (Director) has filed a Form 4 on HARROW HEALTH, INC.
Txns:
| Bought 25,000 shares
@ $13.37, valued at
$334.3k
|
|
12/23/2022 |
4
| Van Horn R. Lawrence (Director) has filed a Form 4 on HARROW HEALTH, INC.
Txns:
| Bought 1,860 shares
@ $13.42, valued at
$25k
|
|
12/14/2022 |
4
| Opaleye Management Inc. (10% Owner) has filed a Form 4 on HARROW HEALTH, INC.
Txns:
| Bought 415,000 shares
@ $10.52, valued at
$4.4M
Bought 16,183 shares
@ $10.52, valued at
$170.2k
|
|
10/03/2022 |
4
| LINDSTROM RICHARD L MD (Director) has filed a Form 4 on HARROW HEALTH, INC.
Txns:
| Sold 40,000 shares
@ $12.62, valued at
$504.8k
|
|
09/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/10/2022 |
4
| LINDSTROM RICHARD L MD (Director) has filed a Form 4 on HARROW HEALTH, INC.
Txns:
| Granted 13,123 options to buy
@ $0 |
|
06/10/2022 |
4
| Van Horn R. Lawrence (Director) has filed a Form 4 on HARROW HEALTH, INC.
Txns:
| Granted 13,123 options to buy
@ $0 |
|
06/10/2022 |
4
| Sternberg Perry J. (Director) has filed a Form 4 on HARROW HEALTH, INC.
Txns:
| Granted 13,123 options to buy
@ $0 |
|
06/10/2022 |
4
| Sparks Teresa (Director) has filed a Form 4 on HARROW HEALTH, INC.
Txns:
| Granted 13,123 options to buy
@ $0 |
|
06/10/2022 |
4
| Makary Martin A. (Director) has filed a Form 4 on HARROW HEALTH, INC.
Txns:
| Granted 13,123 options to buy
@ $0 |
|
04/13/2022 |
4
| Opaleye Management Inc. (10% Owner) has filed a Form 4 on HARROW HEALTH, INC.
Txns:
| Bought 25,000 shares
@ $6.7485, valued at
$168.7k
Bought 3,557 shares
@ $6.7485, valued at
$24k
Bought 10,000 shares
@ $6.7632, valued at
$67.6k
Bought 2,832 shares
@ $6.7632, valued at
$19.2k
|
|
02/23/2022 |
4
| BOLL ANDREW R. (CFO) has filed a Form 4 on HARROW HEALTH, INC.
Txns:
| Paid exercise price by delivering 20,605 shares
@ $7.87, valued at
$162.2k
Exercised 50,000 options to buy
@ $0 |
|
02/23/2022 |
4
| SAHAREK JOHN P. (President, ImprimisRx) has filed a Form 4 on HARROW HEALTH, INC.
Txns:
| Paid exercise price by delivering 25,923 shares
@ $7.87, valued at
$204k
Exercised 50,000 options to buy
@ $0 |
|
01/31/2022 |
4
| Opaleye Management Inc. (10% Owner) has filed a Form 4 on HARROW HEALTH, INC.
Txns:
| Bought 5,000 shares
@ $6.8873, valued at
$34.4k
Bought 1,343 shares
@ $6.8873, valued at
$9.2k
|
|
01/21/2022 |
4
| BAUM MARK L (CEO) has filed a Form 4 on HARROW HEALTH, INC.
Txns:
| Paid exercise price by delivering 71,406 shares
@ $8.33, valued at
$594.8k
Exercised 125,000 options to buy
@ $2.4, valued at
$300k
|
|
09/27/2021 |
4
| LINDSTROM RICHARD L MD (Director) has filed a Form 4 on HARROW HEALTH, INC.
Txns:
| Sold 3,900 shares
@ $10.04, valued at
$39.2k
|
|
09/17/2021 |
4
| LINDSTROM RICHARD L MD (Director) has filed a Form 4 on HARROW HEALTH, INC.
Txns:
| Sold 14,160 shares
@ $9.09, valued at
$128.7k
Sold 5,840 shares
@ $9.02, valued at
$52.7k
|
|
08/23/2021 |
4
| Opaleye Management Inc. (10% Owner) has filed a Form 4 on HARROW HEALTH, INC.
Txns:
| Bought 50,000 shares
@ $8.445, valued at
$422.3k
Bought 2,500 shares
@ $8.445, valued at
$21.1k
|
|
08/19/2021 |
4
| Opaleye Management Inc. (10% Owner) has filed a Form 4 on HARROW HEALTH, INC.
Txns:
| Bought 25,000 shares
@ $8.5661, valued at
$214.2k
Bought 1,000 shares
@ $8.5661, valued at
$8.6k
Bought 45,000 shares
@ $8.6447, valued at
$389k
Bought 1,500 shares
@ $8.6447, valued at
$13k
|
|
07/23/2021 |
4
| BAUM MARK L (CEO) has filed a Form 4 on HARROW HEALTH, INC.
Txns:
| Granted 762,301 restricted stock units
@ $0 |
|
07/23/2021 |
4
| BOLL ANDREW R. (CFO) has filed a Form 4 on HARROW HEALTH, INC.
Txns:
| Granted 346,500 restricted stock units
@ $0 |
|
07/23/2021 |
4
| SAHAREK JOHN P. (President, ImprimisRx) has filed a Form 4 on HARROW HEALTH, INC.
Txns:
| Granted 277,200 options to buy
@ $0 |
|
|
|
|